Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Peripheral Nervous System Diseases

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Peripheral Nervous System Diseases in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research Excerpts

ExcerptRelevanceReference
"Morphine and R-PIA were administered to obtain the dose-response curve and the 50% effective dose (ED(50))."1.33Morphine can enhance the antiallodynic effect of intrathecal R-PIA in rats with nerve ligation injury. ( Cho, SK; Han, SM; Hwang, GS; Hwang, JH, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, JH1
Hwang, GS1
Cho, SK1
Han, SM1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Peripheral Nervous System Diseases

ArticleYear
Morphine can enhance the antiallodynic effect of intrathecal R-PIA in rats with nerve ligation injury.
    Anesthesia and analgesia, 2005, Volume: 100, Issue:2

    Topics: Adenosine A1 Receptor Agonists; Analgesics, Opioid; Animals; Circadian Rhythm; Dose-Response Relatio

2005